Vessel Size and Outcome After Coronary Drug-Eluting Stent Placement
Results From a Large Cohort of Patients Treated With Sirolimus- or Paclitaxel-Eluting Stents
Shpend Elezi, MD*,
Alban Dibra, MD*,
Julinda Mehilli, MD*,
Jürgen Pache, MD*,
Rainer Wessely, MD*,
Albert Schömig, MD and
Adnan Kastrati, MD*,*
* Deutsches Herzzentrum, Technische Universität
First Medizinische Klinik rechts der Isar, Technische Universität, Munich, Germany

View larger version (35K):
[in a new window]
|
Figure 1 Late lumen loss in each vessel size tertile with sirolimus-eluting stents and paclitaxel-eluting stents.
|
|

View larger version (32K):
[in a new window]
|
Figure 2 Target lesion revascularization rate in each vessel size tertile with sirolimus-eluting stents and paclitaxel-eluting stents. Note that a significant difference between the 2 drug-eluting stents is only seen among patients in the lower tertile.
|
|
|